Podcasts about oncologists

In this episode, Himalee Sabnis, MD, MSc, Pediatric Hematologist and Oncologist at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, joins the podcast to discuss bridging gaps in care and facilitating strong communication with patients and families. She also shares insights on strengthening connections across the healthcare journey to support more coordinated and patient-centered care.

What happens when the woman who has spent years treating breast cancer suddenly finds herself sitting on the other side of the diagnosis?In this deeply personal episode of The She Believed She Could™ Podcast, Allison Walsh sits down with Dr. Catherine “Sue” Hwang, a board-certified radiation oncologist specializing in breast cancer, who knows the cancer journey from both sides—as a physician and as a patient.After more than 15 years of caring for women with breast cancer, Dr. Hwang never expected to become a breast cancer patient herself. A routine mammogram revealed calcifications, followed by the discovery of multiple masses and an abnormal lymph node. Suddenly, the physician who understood the treatments, side effects, complications, and statistics was forced to experience the fear and uncertainty of being the patient herself.Dr. Hwang shares what she learned about the patient experience, breast cancer treatment, motherhood, vulnerability, hyper-independence, and accepting support. She talks honestly about how her community rallied around her, from bringing meals to helping with her children, and how the experience completely changed the way she thinks about community and caring for others.But one of the most important lessons came after treatment.Dr. Hwang explains why the end of chemotherapy, surgery, or radiation doesn't necessarily mean the end of the cancer journey. For many women, survivorship can bring an unexpected emotional and physical transition—a period where treatment ends, medical appointments become less frequent, everyone assumes you're okay, and you're left wondering, “What now?”That realization inspired Dr. Hwang to advocate for better breast cancer survivorship care and to help patients understand that struggling after treatment is not a failure. It's part of the journey.She also shares practical advice about mammograms, breast exams, knowing your body, recognizing potential breast cancer symptoms, and becoming your own healthcare advocate. Her message is especially powerful for women who have ever been told they're “too young” to worry about breast cancer or who feel uncomfortable pushing for additional answers.Dr. Hwang's story ultimately comes back to one powerful idea: you don't have to know how you're going to get through the entire journey. Sometimes, you simply have to take the next step.And then the next one.And eventually, you may look back and realize just how much you were capable of all along.What You'll Learn in This EpisodeWhat it's really like when a breast cancer oncologist becomes a cancer patient herselfWhy the period after breast cancer treatment can sometimes be harder than treatment itselfHow to navigate the emotional and physical challenges of cancer survivorship and finding a new normalWhy accepting help and leaning on your community and support system can be a powerful form of strengthHow cancer can change your perspective on motherhood, identity, work, and what truly mattersThe importance of mammograms, knowing your body, and paying attention to changes or symptomsWhy women need to become their own healthcare advocates and seek answers when something doesn't feel rightHow to cope with the fear and uncertainty surrounding cancer recurrenceHow Dr. Hwang's experience as a patient changed the way she now cares for and communicates with breast cancer patientsWhy you don't have to know how you'll get through the entire journey—you can simply take the next step, one day at a timeIf you or someone you know needs support on their cancer journey, visit: http://adventhealthcancerinstitute.com This episode is sponsored by AdventHealth for Women. Learn more about their Women's Health Navigation Team and how they're making healthcare simpler for women and their families at AdventHealthForWomen.com.Join Us at Iconic ImpactReady to create your next incredible chapter?The She Believed She Could™ ICONIC IMPACT takes place November 5, 2026, in The Center for Health and Wellbeing | Winter Park, Florida, bringing together ambitious, accomplished women for meaningful conversations around leadership, visibility, business growth, wellbeing, purpose, and impact. The experience continues November 6 with the exclusive VIP Impact Lab at Hi Hello Labs.

Barbie Matroni, a consultant at Weatherby Healthcare who has spent twelve years working exclusively in the oncology and hematology space, says demand has never been higher. In this episode, she joins us to break down what the oncology locums market actually looks like: why demand has surged since 2020, how continuity of care and flexible schedules coexist, where the need is greatest, and the common questions and misconceptions she hears from physicians. She also shares what separates the oncologists who thrive in locums from those who struggle, and her advice for anyone thinking about dipping a toe in.Enjoyed this episode? Follow The Locumstory Podcast so you don't miss the next one.New to locums? Check out Locumstory's free Crash Course.Ready to talk about locums job opportunities? Learn more about Weatherby Healthcare or browse their open jobs.

Featuring perspectives from Dr Lisa A Carey and Dr Maha Hussain, including the following topics: Introduction (0:00) HER2 History (1:32) Cases from the GMO Survey (7:06) Biology and Selection of First-Line Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer (mBC) — Dr Mahtani (19:56) Faculty Case Presentations (31:37) Patterns of Care Survey — Part 1 (38:26) Optimizing the Use of Up-Front Maintenance Therapy for HER2-Positive mBC — Dr Carey (44:53) Faculty Case Presentations (54:13) CME information and select publications

In this solo episode, Stan The Annuity Man breaks down how to buy annuities the right way and why his no-data, real-time quote platform is changing the industry.   In this episode, The Annuity Man discusses:  Annuities as contractual guarantees, not hypothetical growth The "annuity life coach" and "annuity oncologist" mindset Anonymous, real-time quoting for SPIAs, DIAs, MYGAs, QLACs, and Income Riders Professional boundaries and no-pressure, no-outbound model Direct-to-consumer mission and cleaning up annuity industry "charlatans"   Key Takeaways:  Annuities should only be purchased for what they are contractually guaranteed to do, not for hypothetical or illustrated returns. A truly client-focused advisor is willing to say "you're putting too much into this annuity" or "you might not need this product right now." Providing real-time, anonymous quotes empowers consumers to explore annuity options without fear of being chased by salespeople. Financial advisors should maintain professional distance rather than trying to be friends, golfing buddies, or entertainers. Transforming the annuity industry requires radical transparency, direct-to-consumer access, and a zero-tolerance stance on misleading, high-pressure sales tactics.   "You don't need a friend. You don't need a golfing buddy, and you don't need a meal purchased for you. You need someone telling you the truth." —  Stan The Annuity Man   Connect with The Annuity Man:  Website: http://theannuityman.com/  Email: Stan@TheAnnuityMan.com  Book: Owner's Manuals: https://www.stantheannuityman.com/how-do-annuities-work YouTube: https://www.youtube.com/channel/UCCXKKxvVslbeGAlEc5sra2g  Get a Quote Today: https://www.stantheannuityman.com/annuity-calculator!

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 602.585.9800More HMS: www.holmbergpodcast.com, www.98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Link Up w/The Morning Sickness Digitally All Over:Instagram: @hms_98_official, @bosskupd, @bretvesely, @dickToledoX/Twitter: @HMSon98, @DickToledo, @bretveselyFacebook: @HMSKUPDYouTube: @hmspodcast9320, @98kupdRequest/Call in/Wakeup Song line:(IN AZ) 602.585.9800More HMS: www.holmbergpodcast.com, www.98kupd.comEmail: dtoledo@98kupd.com, bvesely@98kupd.com, bbogen@98kupd.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

US Treasury Secretary Scott Bessent threatened a crackdown Monday on countries doing business with Tehran. Will Tehran be able to withstand the impact, or will the government be forced back to the negotiating table? Karim Sadjadpour, Senior Fellow at the Carnegie Endowment for International Peace, joins the show to discuss.  Also on today's show: Dr. Ezekiel Emanuel, Former Obama White House Health Policy Adviser & Dr. Hussein Tawbi, Oncologist, Univ. of Texas MD Anderson Cancer Center; Frank McKenna, Fmr. Canadian Ambassador to the US    Learn more about your ad choices. Visit podcastchoices.com/adchoices

You're allowed to ask questions. Hearing "no" from an oncology team about a supplement can leave you feeling confused, intimidated, or unsure of what questions to ask next. In this episode, I break down some of the most common concerns I hear around supplements during cancer treatment, including homeopathic remedies, probiotics, organ meat supplements, and Quinton marine plasma minerals. This isn't about choosing conventional medicine over integrative support or the other way around. It's about understanding the concerns, recognizing where nuance matters, and learning how both approaches can work alongside one another. We'll look at why different supplements raise different safety questions, what responsible use can look like, and how having better information can help you advocate more confidently for your child. Because asking questions isn't being difficult. It's part of making informed decisions about your child's care.   LINKS Recommended Tools & Resources: The Untoxin Method If you've spent months caring for everyone else while putting your own health last, the Untoxin Method is created for you. This guided 21-day detox program includes a prep week, a 7-day reset, and a gradual transition back to everyday life. You'll receive: A complete detox supplement kit Simple, done-for-you meal plans A step-by-step daily protocol Live coaching and accountability A supportive community of parents and caregivers who understand the journey If you're ready to restore your energy and prioritize your own healing, learn more and register here: https://seasonjohnson.info/join-today   Fullscript (Practitioner-Grade Supplements) If you're looking for high-quality, practitioner-grade supplements to support your health, Season has created a hand-curated Fullscript dispensary with the exact products she trusts and uses in practice. You'll also receive 15% off your first order plus 5% off for life as a podcast listener. https://bit.ly/seasonsfullscript   Community & Support: Join Thrive Through Cancer Community: https://biodynamicwellness.com/thrive-through-cancer  Thrive Beyond Cancer Program: https://biodynamicwellness.com/thrive-beyond-cancer Learn More About Biodynamic Wellness: https://biodynamicwellness.com   Connect with Season: Website: seasonjohnson.com Follow along on Instagram: @seasonjohnson Follow Season on Facebook: Season Johnson

Listen to JCO's art of Oncology article, "The Patient Who Could Not Die," by Dr. Erika Ramsdale, who is an Associate Professor of Medicine in the Division of Hematology/Oncology at the Wilmot Cancer Institute, University of Rochester Medical Center. The article is followed by an interview with Ramsdale and host Dr. Mikkael Sekeres. Dr. Ramsdale meets a patient who was never born and would never die and considers what AI can (and can't) teach about the art of connection. LINK TO FULL TRANSCRIPT

In this episode, Scott Becker discusses the growing shortage of oncologists, the rising demand for cancer care, and the challenges patients face accessing specialized care. 

In this episode, Scott Becker discusses the growing shortage of oncologists, the rising demand for cancer care, and the challenges patients face accessing specialized care. 

For many young women diagnosed with breast cancer, some of the most important decisions they will ever make happen within days of hearing the words, "You have cancer." While treatment planning begins immediately, patients may also be faced with urgent questions about fertility, future family-building, and preserving options they may not have expected to think about so soon. These conversations often happen during a period of fear, uncertainty, and information overload, leaving many patients feeling overwhelmed and unprepared. In this episode, I'm joined by Dr. Ann Partridge, Vice Chair of Medical Oncology and Chief Clinical Strategy Officer at Dana-Farber Cancer Institute, where she also serves as co-founder and director of the Program for Young Adults with Breast Cancer. A professor at Harvard Medical School, Dr. Partridge is a leading breast oncologist and researcher whose work focuses on improving care and outcomes for young adults with breast cancer. Together, we discuss how breast cancer treatment can affect fertility, why these conversations need to happen early, the options available today, and how patients can make informed decisions while balancing the urgency of cancer treatment with hopes and plans for the future. We also reinforce the hopeful message that having children after breast cancer is often possible - and that preserving future options begins with having the right conversations early. Most importantly, this episode is a reminder that patients deserve information, support, and compassionate guidance when facing life-changing decisions at diagnosis. Resources Mentioned in This Episode For additional information and support, visit the Young and Strong Program at Dana-Farber Cancer Institute, which offers resources and practical guides for young adults with breast cancer, including those who are newly diagnosed, in treatment, or in survivorship, as well as caregivers. The program also provides trusted information about fertility preservation, pregnancy after breast cancer, and breastfeeding. The information shared on Dear Cancer, I'm Beautiful is for educational and informational purposes only and is not intended as medical advice. Always consult your physician or qualified healthcare provider regarding your individual medical care and treatment decisions. The views and opinions expressed by guests are their own and do not necessarily reflect those of Cancer Fashionista. Thank you to Daiichi Sankyo and Novartis for making this episode of the Signature Series possible.

In this episode, Scott Becker discusses the growing shortage of oncologists, the rising demand for cancer care, and the challenges patients face accessing specialized care.

Kathy talks with Charlotte Bayala, host of The Cancer Caregiver and Caregiver Breathing Room podcasts. Charlotte is also a yoga and meditation teacher and a caregiver for her husband who was diagnosed with cancer over a decade ago. Tune in and learn what inspired Charlotte to start the podcasts, how it has helped her as a caregiver, what she does so she doesn't lose her shit, and why sarcasm and humor are important for caregivers. Listen to The Cancer Caregiver and Caregiver Breathing Room and follow Charlotte on Instagram.Follow Women Who Sarcast podcast on IG @womenwhosarcast and Women Who Podcast magazine @womenwhopodcastmagazine. Get the current issue of Women Who Podcast magazine at womenwhopodcastmag.com.Show music provided by Drrrakhan.All content © 2026 Women Who Sarcast and WWS Productions.

Can a blind, evolutionary process account for who we are and why we're here? Is there anything beyond this life? On this ID The Future, enjoy a conversation with veteran oncologist, author, and speaker Dr. Stephen Iacobini. In this conversation, originally aired on the Ex-Skeptic podcast and hosted by Jana Harmon, Dr. Iacoboni shares his journey from childhood faith to scientific atheism and back to theistic belief. Along the way, he examines the failures of naturalism, the role of science, and the undeniable human longing for meaning that points to something beyond life itself. Source

The Future of Medicine Podcast, where we believe in promoting overall health and prevention over just treating sickness. Join us for the latest in medical advancements and expert advice. Subscribe and explore: https://youtube.com/@BrentwoodMD Last time Dr. Natalie Spradlin joined me on the podcast, we talked about the moments right after a patient finds out they might have cancer. We covered important topics like protecting your mental energy, getting a second opinion, and how to walk into that first oncology appointment as prepared as possible. If you missed it, When You Hear the Word “Cancer” is worth a read. As an assistant professor of hematology and oncology at Vanderbilt-Ingram Cancer Center, a co-director of Vanderbilt's Internal Medicine Miller Society, and a board-certified hematologist and oncologist with more than 14 years of clinical experience, Dr. Spradlin brings a unique perspective to topics that weigh on many people's minds. In our latest discussion, we take a look at evidence-backed ways to reduce cancer risk and detect cancer early, as well as the major types of cancer treatments and the role of clinical trials if you do receive a cancer diagnosis. Chapters (00:00:01) - Interview(00:01:41) - Lifestyle risk factors to prevent cancer(00:04:41) - Cancer Screening and Genetic Testing(00:10:11) - Wonders of the World: Whole Body MRIs(00:16:02) - AI in breast cancer diagnostics(00:19:13) - Talking About Cancer Therapeutics(00:19:51) - Treatment of cancer with three modalities(00:26:41) - Immunity Therapy: What is it?(00:30:08) - Clinical Trials(00:35:30) - Phase 1 cancer trials(00:38:35) - Screening for colorectal cancer options(00:41:07) - How to connect with your doctor about cancer at Vanderbilt(00:41:57) - Brentwood MD: A Celebration of the Podcast

Matt Smith, 42, metastatic prostate cancer, Wilmington, NC, with Michael Serzan, Medical Oncologist, Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute

Medicine is becoming too complex for any one clinician to keep up with alone. AI may soon change that equation. Dr. Francisco Esteva joins Dr. Sanjay Juneja and Dr. Doug Flora to explain how physicians can use AI to research faster, communicate more clearly with patients, automate repetitive work, and build systems that extend their expertise. Francisco began learning these tools around age 60. Today, he's building AI-powered workflows for patient education, YouTube, research, quality control, and automation. You don't have to become an AI expert. But understanding how to use these tools may soon become an essential clinical skill.

In this episode of SurgOnc Today®, Drs. Uriel Clemente, Eduardo Guzman and Justin Shinn discuss the evaluation and management of incidental salivary gland findings. The conversation focuses on practical clinical decision-making, including imaging workup, tissue diagnosis, PET-avid lesions, and when referral to a head and neck surgeon is warranted.

When should I be referred for heart care during cancer treatment? Roland Njei, MD, board-certified cardiologist who specializes in Cardio-Oncology and practices at Franciscan Health, explains when a referral helps. Learn which baseline risk factors (blood pressure, diabetes, prior heart disease) and treatments prompt evaluation, what tests a cardio-oncologist will order (echo, high-sensitivity troponin, EKG), and how oncologists, cardiologists, and primary care work together to decide if specialist follow-up is needed.

Send us Fan Mail

Editor's Choice:  Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: 2026 updateEditorial: The evolving landscape of personalized perioperative care: A commentary on the 2026 ERAS® Gynecologic oncology guidelinesHosted by: Sean C. Dowdy, MD; Division of Gynecologic Oncology, Mayo Clinic College of Medicine, Rochester, MN, USAFeaturing: Gregg Nelson, MD, PhD; Department of Obstetrics & Gynecology, Cumming School of Medicine, University of Calgary, Calgary, Alberta, CanadaRichard D. Urman, MD; Department of Anesthesiology, The Ohio State University Wexner Medical Center and College of Medicine, Columbus, OH, USAOlle Ljungqvist, MD, PhD; Department of Molecular Medicine & Surgery, Karolinska Institutet, Stockholm, SwedenCheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net

Send us Fan Mail

In this episode, Dr. Linda Bosserman shares her expertise on hormone therapy, addressing common misconceptions and highlighting the latest science supporting their safe use in women and men. Tune in to hear practical insights on hormone management, systemic and local applications, and how to advocate for your health.Key Topics Covered:The importance of precise language: specifying hormone types, routes, and dosesThe safety and efficacy of vaginal estrogen in women with breast cancerDebunking myths about hormones causing breast cancer: data from large studiesThe potential of testosterone in improving neurocognition, libido, and overall health in womenThe ongoing fight for FDA approval of female testosterone productsThe role of systemic hormones in preventing cardiovascular diseaseHow to counsel patients on hormone-related recurrence risksThe significance of personalized, evidence-based hormone therapy for optimal agingInsights from Dr. Bosserman's PhD in sex therapy and its relevance to sexual healthThe systemic biases and misinformation perpetuated by media and outdated guidelinesDr. BossermanMenopausal Hormone Therapy after Breast CancerSubscribe, leave a review, and share this episode with someone who needs it.

Oncologist Dr. Saeed Rafii Explains  Why Women In The UAE Being Diagnosed With Breast Cancer Younger

Listen to JCO's Art of Oncology article, "Taking Responsibility" by Dr. Katherine Hicks-Courant, who is a gynecologic oncologist at Penn Medicine Lancaster General Health. The article is followed by an interview with Hicks-Courant and host Dr. Mikkael Sekeres. Dr Hicks-Courant shares how caring for her father with ALS unexpectedly shaped how she approached her work as a gynecologic oncologist. LINK TO FULL TRANSCRIPT

No-nonsense advice on sleep, diet, exercise, social connection, keeping your brain sharp, and not being a schmuck. Ezekiel J. Emanuel, MD, PhD is a Vice Provost and Professor at the University of Pennsylvania. A bioethicist, health policy expert, and oncologist, he was one of the architects of the Affordable Care Act. He is a regular guest on CNN and MSNBC and frequently contributes to The New York Times, The Washington Post, The Wall Street Journal, and The Atlantic. His new book is Eat Your Ice Cream: Six Simple Rules for a Long and Healthy Life. In this episode we talk about: Why longevity shouldn't be the goal — and what to aim for instead The single most powerful intervention for a long, healthy life (hint: it's not exercise) The neuroscience of friendship: how social connection literally changes your brain and body Six practical, science-backed rules for living well — from an oncologist with nothing to sell Why ultra-processed food and sugary drinks are doing more damage than almost anything else The case for eating ice cream (yes, really) — and why moderation is the new discipline What retirement does to your brain, and how to protect your cognitive function as you age ChatGPT as a diagnostic tool — and what a doctor actually thinks about that Why the wellness industrial complex is making you worse, not better Get the 10% with Dan Harris app here Sign up for Dan's free newsletter here Follow Dan on social: Instagram, TikTok Subscribe to our YouTube Channel To advertise on the show, contact sales@advertisecast.com or visit https://advertising.libsyn.com/10HappierwithDanHarris This episode is sponsored by:  BiOptimizers: Magnesium Breakthrough delivers seven forms of magnesium to support your nervous system, stress response, and daily recovery. Try it risk-free with their 365-day guarantee — head to bioptimizers.com/happier and use code HAPPIER for 15% off plus free gifts at checkout. Eight Sleep: The Pod automatically heats and cools your bed, tracks your sleep without a wearable, and their testing shows users get up to 34% more deep sleep. Use code DanHarris at eightsleep.com/danharris for up to $350 off the Pod 5, with a 30-day trial if it's not for you.

As colorectal cancer rates rise among younger adults, surgeons are increasingly caring for patients with rectal cancer who are pregnant or hoping to preserve future fertility. With more individuals delaying childbearing, balancing effective cancer treatment with fertility preservation and maternal–fetal safety has become an important clinical challenge. This timely topic was recently highlighted by Dr. Sharon Suwanabol during a presentation at the American Society of Colon and Rectal Surgeons annual meeting 2026. In this episode, we explore the intersection of rectal cancer, fertility, and pregnancy through a multidisciplinary, case-based discussion. We review how surgery, chemotherapy, and pelvic radiation can affect fertility and sexual function in both men and women, and why early counseling and referral to reproductive endocrinology specialists are essential. The discussion also emphasizes that evaluation and treatment during pregnancy can often be performed safely, with care individualized based on tumor stage, gestational age, and the patient's goals and values. Hosts and discussants ·      Dr. Betelhem Yohannes, General surgery resident at the University of Washington ·      Dr. Griffen Allen, General surgery resident at the University of Washington  ·      Dr. Raga Siddharthan, Assistant Professor of Surgery in the Section of Colorectal Surgery at the University of Washington  ·      Dr. Stacey Cohen, Professor in the Division of Hematology and Oncology at the University of Washington and a gastrointestinal medical oncologist at Fred Hutch Cancer Center, specializing in colorectal and other GI cancers. Learning objectives ·      Describe the impact of rectal cancer surgery on fertility, sexual function, and future childbearing potential. ·      Review the effects of chemotherapy and pelvic radiation on reproductive health and fertility preservation. ·      Discuss available fertility preservation strategies and the importance of early pre-treatment counseling and referral. ·      Recognize the diagnostic challenges of rectal cancer during pregnancy, including overlapping gastrointestinal symptoms. ·      Review appropriate staging and workup considerations for suspected rectal cancer in pregnant patients. ·      Discuss multidisciplinary management strategies for rectal cancer during pregnancy, including individualized treatment sequencing. ·      Examine ethical and patient-centered considerations when balancing maternal cancer treatment and fetal outcomes. References  Siegel RL, Wagle NS, Star J, Kratzer TB, Smith RA, Jemal A. Colorectal cancer statistics, 2026. CA Cancer J Clin. 2026;76(2):e70067. doi:10.3322/caac.70067 [https://pubmed.ncbi.nlm.nih.gov/38240409/] Pregnancy at Age 35 Years or Older: ACOG Obstetric Care Consensus No. 11. Obstet Gynecol. 2022;140(2):348-366. doi:10.1097/AOG.0000000000004873 [https://pubmed.ncbi.nlm.nih.gov/35640237/] Stal J, YI SY, Cohen-Cutler S, et al. Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates. Oncologist. 2022;27(7):579-586. doi:10.1093/oncolo/oyac052 [https://pubmed.ncbi.nlm.nih.gov/35708892/] Druvefors E, Myrelid P, Andersson RE, Landerholm K. Female and Male Fertility after Colectomy and Reconstructive Surgery in Inflammatory Bowel Disease: A National Cohort Study from Sweden. J Crohns Colitis. 2023;17(10):1631-1638. doi:10.1093/ecco-jcc/jjad079 [https://pubmed.ncbi.nlm.nih.gov/37341355/] Ito M, Tsukada Y, Watanabe J, et al. Long-term survival and functional outcomes of laparoscopic surgery for clinical stage I ultra-low rectal cancers located within 5 cm of the anal verge: A prospective phase II trial (Ultimate trial). Ann Surg. Published online April 1, 2024. doi:10.1097/SLA.0000000000006290 [https://pubmed.ncbi.nlm.nih.gov/38629555/] Teh WT, Stern C, Chander S, Hickey M. The impact of uterine radiation on subsequent fertility and pregnancy outcomes. Biomed Res Int. 2014;2014:482968.  Johnson GGRJ, Park J, Helewa RM, Goldenberg BA, Nashed M, Hyun E. Total neoadjuvant therapy for rectal cancer: a guide for surgeons. Can J Surg. 2023 Apr 21;66(2):E196-E201. doi: 10.1503/cjs.005822. PMID: 37085291; PMCID: PMC10125160. [https://pubmed.ncbi.nlm.nih.gov/37085291/] Naren G, Guo J, Bai Q, Fan N, Nashun B. Reproductive and developmental toxicities of 5-fluorouracil in model organisms and humans. Expert Rev Mol Med. 2022 Jan 31;24:e9. doi: 10.1017/erm.2022.3. PMID: 35098910; PMCID: PMC9884763. [https://pubmed.ncbi.nlm.nih.gov/35098910/] National Comprehensive Cancer Network. (2026). NCCN Clinical Practice Guidelines in Oncology: Rectal Cancer (Version 2.2026). Retrieved from NCCN Guidelines for Rectal Cancer [https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1449] Oktay, Kutluk M.D., Ph.D.. Expert Commentary on Fertility Preservation in Colorectal Cancers: Current State and Practical Tips for the Cancer Practitioner. Diseases of the Colon & Rectum 63(6):p 726-727, June 2020. | DOI: 10.1097/DCR.0000000000001688 [https://pubmed.ncbi.nlm.nih.gov/32479532/] Stal J, YI SY, Cohen-Cutler S, et al. Fertility Preservation Discussions Between Young Adult Rectal Cancer Survivors and Their Providers: Sex-Specific Prevalence and Correlates. Oncologist. 2022;27(7):579-586. doi:10.1093/oncolo/oyac052 [https://pubmed.ncbi.nlm.nih.gov/35708892/] Gentile G, Ciccarone M. Management of fertility preservation in young female patients with gastrointestinal cancer: A case series and systematic literature review. Curr Probl Cancer. 2025;57:101221. doi:10.1016/j.currproblcancer.2025.101221 [https://pubmed.ncbi.nlm.nih.gov/39598263/] Saif MW. Management of colorectal cancer in pregnancy: a multimodality approach. Clin Colorectal Cancer. 2005;5(4):247-256. doi:10.3816/ccc.2005.n.035 [https://pubmed.ncbi.nlm.nih.gov/16183863/] Rogers JE, Dasari A, Eng C. The Treatment of Colorectal Cancer During Pregnancy: Cytotoxic Chemotherapy and Targeted Therapy Challenges. Oncologist. 2016 May;21(5):563-70. doi: 10.1634/theoncologist.2015-0362. Epub 2016 Mar 21. PMID: 27000464; PMCID: PMC4861360. [https://pubmed.ncbi.nlm.nih.gov/27000464/] Jiang Q, Hua H. Fertility in young-onset colorectal patients with cancer: a review. Oncologist. 2024;29(10):e1237-e1245. doi:10.1093/oncolo/oyae141 [https://pubmed.ncbi.nlm.nih.gov/39292850/] Dolmans MM, Hollanders de Ouderaen S, Demylle D, Pirard C. Utilization rates and results of long-term embryo cryopreservation before gonadotoxic treatment. J Assist Reprod Genet. 2015;32(8):1233-1237. doi:10.1007/s10815-015-0533-z [https://pubmed.ncbi.nlm.nih.gov/26162569/ Moawad NS, Santamaria E, Rhoton-Vlasak A, Lightsey JL. Laparoscopic Ovarian Transposition Before Pelvic Cancer Treatment: Ovarian Function and Fertility Preservation. J Minim Invasive Gynecol. 2017;24(1):28-35. doi:10.1016/j.jmig.2016.08.831 [https://pubmed.ncbi.nlm.nih.gov/27599763/] Fish R. Ovarian transposition in rectal cancer: uncertain benefit at a high price. Colorectal Dis. 2022;24(6):706-707. doi:10.1111/codi.16086 [https://pubmed.ncbi.nlm.nih.gov/35191146/] Ribeiro R, Baiocchi G, Moretti-Marques R, Linhares JC, Costa CN, Pareja R. Uterine transposition for fertility and ovarian function preservation after radiotherapy. Int J Gynecol Cancer. 2023;33(12):1837-1842. Published 2023 Dec 4. doi:10.1136/ijgc-2023-004723 [https://pubmed.ncbi.nlm.nih.gov/38104863/] Haggar F, Pereira G, Preen D, et al. Maternal and neonatal outcomes in pregnancies following colorectal cancer. Surg Endosc. 2013;27(7):2327-2336. doi:10.1007/s00464-012-2774-6 [https://pubmed.ncbi.nlm.nih.gov/23645367/] Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium: https://behindtheknife.org/premiumOral Board Review: https://behindtheknife.org/oral-boardOral Board Simulator: https://behindtheknife.org/oral-board/simulatorGeneral Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of All Talk Oncology, host Kenny Perkins speaks with Dr. Shruti Patel, a GI medical oncologist from Stanford University, about the rising rates of early-onset colorectal and GI cancers and what they mean for patients today. Dr. Patel explains why more younger patients are being diagnosed, explores possible contributing factors like lifestyle and environmental changes, and emphasizes that there is no single cause of cancer. She also breaks down how clinical trials work, why patient advocacy matters, and how resources like clinicaltrials.gov can help guide treatment decisions. The conversation also dives into survivorship care and why life after cancer should be viewed as “life with a cancer history,” highlighting the ongoing physical, emotional, and financial challenges patients may face. In this episode, Dr. Patel discusses: The rising rates of early-onset colorectal and GI cancers Why younger patients are increasingly being diagnosed Possible contributing factors (diet, lifestyle, environmental influences) Why no single “smoking gun” explains cancer development How clinical trials work (Phase I, II, and III differences) Why patients should use clinicaltrials.gov and advocate for themselves The importance of second opinions in cancer care Why survivorship should be viewed as “life with a cancer history” Physical, emotional, and financial challenges after treatment The problem of patient guilt and blaming lifestyle choices Dr. Patel's insights offer a clear, compassionate, and empowering look into modern cancer care helping patients, caregivers, and clinicians better understand both the science and the human experience behind a diagnosis.   Immortalize your voice by being an ALL TALK ONCOLOGY GUEST! Just fill-out this FORM. Invite Kenny Perkins to Speak or Participate on your event. Just fill-out this FORM.   SOCIAL MEDIA LINKS: All Talk Oncology: Instagram & Facebook JOIN OUR FREE COMMUNITY: Facebook Community WEBSITE: www.alltalkoncology.com

The Advantage of Rapid Prototyping in Wearable MedTech DevelopmentModern cancer treatments are getting better at targeting specific forms of cancer. However, this improved effectiveness often introduces lethal side effects. Skribe Medical is developing wearable technologies to help oncologists monitor and manage these side effects and ultimately improve cancer survivability.In Episode 45 of the MedTech Speed to Data podcast, Key Tech's Andy Rogers has a conversation with Ryan Neely, Skribe Medical's CEO and co-founder, about the startup's approach to rapid prototyping, clinical trials, and wearable technology.Need to knowCancer treatment can be lethal — The most effective drugs often come with black box warnings of harmful and lethal side effects.600,000 US patients are at risk of cardiotoxicity — Toxic drugs damage the heart, leading to complications like arrhythmia and heart failure.Managing cardiotoxicity can delay cancer treatments — Oncologists must now schedule patients for third-party ECG testing, which takes time and delays treatment.The nitty-grittySkribe Medical is developing a wearable ultrasound sensor that detects cardiotoxicity signals for use in oncology clinics. “We have a patch that can be worn to detect cardiotoxicity and really streamline monitoring of heart health,” Neely says. “Rather than an oncologist sending a patient to get a cardiac ultrasound, which could take weeks, the patch can just be placed above the heart for about five minutes. We record a bunch of different signals, pass them through an AI model, and then we can give them either a thumbs up or a thumbs down.”Neely goes on to explain how the in-clinic wearable approach delivers benefits beyond better patient outcomes. “The first device that we're building is intended to be used in the clinic by a nurse or a medical assistant. By the time the doctor is there, you've got your answer.”Designing a wearable device rather than an implant created several advantages for Skribe Medical during its early development. “In a regulated industry like medical devices,” Neely explains, “it's like a little bit of a chicken and egg where people say, ‘we'd like to see some clinical validation' and you're thinking, ‘Well, I don't have a million dollars to fund that.' In a non-invasive device, any opportunity that you can have to test, even if it's this big, bulky thing, you can get some data.”Skribe Medical's technology can extend to other aspects of oncology, including peripartum cardiomyopathy, a rare form of heart failure arising towards the end of a pregnancy. Long-term, Neely envisions building the longitudinal training data needed for predictive monitoring. “What we'd like to do is be able to say, ‘two weeks from now there might be an issue' so you can do something today that prevents any drop [in injection fraction] at all.”Data that made the difference:Skribe Medical's three founders built first prototype at home. They used their home electronics and 3D printing labs to rapidly prototype the first functional sensors.Rapid wearable development delivered data quickly, first by testing themselves and then through clinical testing.Skribe Medical conducted the first clinical tests at an ECG lab where, with consent, the wearable collected patient data for comparison with the patient's ECG results.Having clinical data so early in the process encouraged investors. Last year's pre-seed round raised $1.6 million from angels and VCs to support the next phase of device development and trials.Listen to Andy's conversation with Neely to hear more about Skribe Medical's journey, development process, and the advantages of wearable medical technology.

In this episode Dr. Patrick Moore, MD (oncologist and hematologist, Riverside Cancer Institute) explains the difference between oncology and hematology, what common conditions we treat, and why early detection matters. Learn how cancer screening, blood tests (CBC), and routine primary care visits can catch problems early so treatment — from surgery to chemotherapy and targeted therapy — can be most effective. Friendly, clear guidance for patients and families navigating cancer care.

HOST:  Hildy Grossman CO-HOST:  Jordan Rich GUESTS: Kyle Concannon, MD, Samantha Murrell, Bianca Bye and Leah Phillips The face of lung cancer is changing. No longer viewed simply as a “smoker’s disease” that only impacts older adults, there is a rising and concerning trend of younger adults and non-smokers being diagnosed with advanced disease.  Our guests today have so much light to shine on this issue. In this powerhouse episode, we hear from Samantha Murrell, diagnosed with Stage 4 with a HER2 biomarker at age 37. She notes that her way of coping with her diagnosis was to learn everything possible about her disease. She tells how hope comes with new, cutting-edge drugs targeting HER2 because they allow her to live a full and active life.   Our guest, Leah Phillips, a mother of three young children, also was shocked by her diagnosis of Stage 4 lung cancer at 43. She tells how she joined Bianca Bye, who faced the advanced diagnosis and tragic loss of both parents, within months of each other, to lung cancer. Leah and Bianca joined forces to create the Young Lung Cancer Initiative. Oncologist, Dr. Kyle Concannon notes how these three resilient women are finding meaning in advocacy as they work to transform suffering into meaning by helping others. This is an unforgettable, action-driven look at hope, survival, and taking control.

Every year, millions of people's medical care runs into the roadblock known as prior authorization, which requires an insurer to sign off before chemotherapy, surgery or countless other services can proceed. Who does this often onerous process help, who does it hurt and how could it work better for everyone?Guests:Tom Roberts, Oncologist, Mass General Cancer CenterAaron Schwartz, Assistant Professor, Department of Medical Ethics and Health Policy and Department of Medicine, University of PennsylvaniaKathleen, CaregiverLearn more on our website.Want more Tradeoffs? Sign up for our free weekly newsletter featuring the latest health policy research and news.Support this type of journalism today, with a gift. Hosted on Acast. See acast.com/privacy for more information.

Listen in as I talk to Dr. Jeanette LinderWhat happens when a physician stops ignoring her own body and finally begins to listen?Dr. Linder is an Oncologist and Functional & Integrative Medicine physician who transformed her own health after years of exhaustion, overwork, and burnout.Now, she's helping women remove the shame surrounding health, reconnect with their bodies, and build sustainable wellness rooted in grace, healing, and real life.This conversation is powerful, honest, and deeply needed for women who have spent years pouring into everyone else while neglecting themselves.This series was created to bring women together through authentic storytelling because we understand that one woman's testimony can help another woman survive, heal, and thrive. This episode is no exception.Watch by downloading the CTR Media Network App on:Roku • Amazon Fire TV • Android TV • Apple TV • iOS App • Google Play App • Web AppAlso available across social media, podcast streaming platforms, radio, and digital media outlets.The journey share series...conversations that remind us that our stories have power. #JourneyShareSeries #LevelingUpPodcast #AlethiaTucker #MoniquePearson #SoaringWithoutLimits #WomenWhoInspire #WomenEmpoweringWomen #PurposeInMotion #Reinvention #Women40Plus #HealingAndGrowth #WomenInLeadership #AuthenticConversations #CTRMediaNetworkSPONSORS Tandra Price TapIn Magazinehttps://www.tapinmagazine.org/about-tap-in-magazineInstagram: @tapinmazine & Tandra PriceWould you like to be a guest or sponsor? Contact us at: ⁠⁠⁠https://www.levelingupthepodcast.com/shop⁠⁠⁠ Reach Dr. Alethia Tucker by going to: Email: ⁠atucker@joleaseenterprises.com⁠ LinkedIn: ⁠https://www.linkedin.com/in/coachalethiatucker⁠Instagram: ⁠https://www.instagram.com/alethiaatucker⁠ Instagram: ⁠https://www.instagram.com/joleaseenterprises/⁠Facebook: ⁠Alethia Tucker

Smarter treatment paths often begin with asking better questions about what truly works and what simply sounds promising.In this episode, Dr. Stephen Petteruti explains why repurposed drugs are gaining attention in prostate cancer care. He challenges conventional therapies that often offer limited survival benefit despite significant side effects, and highlights how publication bias and interpretation of data can shape treatment narratives. Dr. Stephen outlines how repurposed drugs are selected. Rather than relying on a single solution, he emphasizes synergy: combining therapies like sirolimus and select statins to target cancer pathways while supporting overall health.  If you value longevity and informed decision-making, take a moment to rethink your options. Tune in to the full episode of Repurposed Drugs for Prostate Cancer: What Your Oncologist Will Never Tell You.Enjoy the podcast? Subscribe and leave a 5-star review on your favorite platforms.Dr. Stephen Petteruti is a board-certified physician specializing in longevity-focused, integrative medicine. He works with men navigating prostate cancer, testosterone and hormone health, aging, and performance using proactive, evidence-informed strategies grounded in real clinical practice. His approach prioritizes preserving function, strength, and quality of life while helping patients make clear, informed decisions beyond reactive, fear-driven care.Learn more: https://www.drstephenpetteruti.com/ Learn more: https://www.intellectualmedicine.com/ Connect with Dr. Petteruti on:⁠Instagram: ⁠https://www.instagram.com/dr.stephenpetteruti/⁠ Facebook: ⁠https://www.facebook.com/dr.stephenpetteruti⁠ Subscribe to Intellectual Medicine on:Apple Podcast: https://tinyurl.com/DrPetterutiApplePodcast Spotify: https://tinyurl.com/DrPetterutiSpotifyPodcast Disclaimer:The content presented in this video reflects the opinions and clinical experience of Dr. Stephen Petteruti and is intended for informational and educational purposes only. It is not medical advice and should not be used as a substitute for professional diagnosis, treatment, or guidance from your personal healthcare provider. Always consult your physician or qualified healthcare professional before making any changes to your health regimen or treatment plan.Produced by https://www.BroadcastYourAuthority.com 

In this episode, Jeff Malec sits down with Dr. Patrick Welton to trace his remarkable path from Wisconsin kid to Stanford oncologist to veteran futures trader and founder of Welton Investment Partners. Patrick shares how trading pork bellies and interest rate futures in the late 1970s to pay tuition evolved into a decades-long career shaped by mentors at Commodities Corp, relationships with legends like Paul Tudor Jones and John Henry, and a unique “outside inside trader” role that let him keep practicing medicine at Stanford while managing money. He explains how his medical background and scientific training influence his approach to risk, uncertainty, and decision-making, and breaks down Welton's strategy mix across trend following, macro, short-term flow trading, and equity selloff protection. Along the way, Patrick and Jeff dig into the myths around trend following “dying,” why diversification and staying power matter more than narratives, how capital flows really drive short-term moves, and what it takes to survive for 30+ years in a business where most firms disappear. SEND IT!Chapters:00:00-02:03=Intro02:04-09:40=Doctor to Trader: Patrick Welton's Origin Story, From Wauwatosa to Futures and the ER09:41-30:03= From 1987 Crash to Commodities Corp: How Patrick and Annette Turned a Side Hustle into a Trading Career30:04-43:19= Doctors, Scientists, and Traders: Embracing Uncertainty, Reflexivity, and the Real Drivers of Trend Following43:20-56:16= AI, Innovation, and the “CTA Winter”: Cycles, Flows, and the Future of Trend Following56:17-01:14:19= Building Welton's Playbook: Diversifying Alpha, Short-Term Flows, and the Art of Surviving as an Asset Manager01:14:20-01:29:48= Alt Data, Capital Flows, and What Really Matters: Patrick Welton on Research, Edges, and the Future of Trading01:29:49-01:37:47= End-of-Month Myths, Market Microstructure, and the Limits of Short-Term EdgesFrom the Episode: Leverage Is Bad. Except When It Isn't. Morningstar Just Made the Distinction OfficialBook: Richer, Wiser, Happier: How the World's Greatest Investors Win in Markets and Life Book: Market Wizards, Updated: Interviews with Top TradersJack Schwager on The DerivativeFollow along with Dr. Welton and Welton Investment Partners on LinkedIn and be sure to check out Welton's website at welton.com for more information!Don't forget to subscribe to⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The Derivative⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, follow us on Twitter at⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠@rcmAlts⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠sign-up for our blog digest⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.Disclaimer: This podcast is provided for informational purposes only and should not be relied upon as legal, business, or tax advice. All opinions expressed by podcast participants are solely their own opinions and do not necessarily reflect the opinions of RCM Alternatives, their affiliates, or companies featured. Due to industry regulations, participants on this podcast are instructed not to make specific trade recommendations, nor reference past or potential profits. And listeners are reminded that managed futures, commodity trading, and other alternative investments are complex and carry a risk of substantial losses. As such, they are not suitable for all investors. For more information, visit⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.rcmalternatives.com/disclaimer⁠⁠⁠⁠

What happens when the world's leading expert on breast cancer becomes the patient? In this episode, we sit down with Dr. Marisa Weiss, renowned oncologist and founder of Breastcancer.org, to discuss her unique 360-degree perspective on the disease. Dr. Weiss shares the raw reality of her own diagnosis and how it shifted her understanding of patient care. We dive deep into the evolving landscape of breast cancer treatment—from targeted therapies to the importance of lifestyle changes—and why "informed decision-making" is the most powerful tool a patient can have.  Dr. Weiss breaks down the "information overload" that often follows a diagnosis and offers a roadmap for navigating treatment with clarity and confidence. We explore the vital importance of listening to your body, asking the "hard" questions to your medical team, and the lifestyle shifts that can impact long-term health. Whether you are currently in treatment, a survivor, or looking to lower your risk, Dr. Weiss provides essential advice on how to be your own best advocate in a complex medical system. Follow Dr. Weiss on Instagram: @drmarisaweiss Follow Breastcancer.org on Instagram: @breastcancerorg Follow us on Instagram: @every.body.talks @jenngiamo @schully Subscribe to our YouTube channel! Don't forget to subscribe to the podcast for free wherever you're listening. Apple Podcasts Spotify Be sure to leave a 5 star rating! It really helps grow the show. If you like the show, telling a friend about it would be amazing!

In this episode, Muhamed Baljevic, MD, FACP, and Johnathan Ticku, MD, discuss various strategies to optimize the use of bispecific antibodies in their practices for the treatment of R/R MM through patient monitoring, dosing in outpatient settings, and using tocilizumab and IVIG, among other management strategies.  Presenters:  Muhamed Baljevic, MD, FACP Associate Professor of Medicine Division of Hematology-Oncology Department of Medicine Director, Multiple Myeloma Program Director, Vanderbilt Amyloidosis Multidisciplinary Program (VAMP) Co-Chair, Scientific Review Committee, VICC Disease Team Lead, Plasma Cell Dyscrasias and Lymphomas Vanderbilt-Ingram Cancer Center Vanderbilt University Medical Center Nashville, Tennessee Jonathan Ticku, MD Medical Oncologist and Hematologist GU Oncology Lead, Mayo Clinic Health System Assistant Professor of Oncology, Mayo Clinic La Crosse, Wisconsin Link to full program: https://bit.ly/4u0xH6q Get access to all of our new podcasts by subscribing to the Decera Clinical Education Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Yale Cancer Center Director Dr. Eric Winer is interviewed by Dr. Melinda Irwin about becoming on oncologist and the latest advances and challenges in treating cancer. April 26, 2026 Yale Cancer Center Visit: https://medicine.yale.edu/cancer/ Email: canceranswers@yale.edu Call 203-785-4095

I was recently talking to an oncologist about health communication when he mentioned The Pitt, that hit medical drama set in an emergency department in Pittsburgh. Now in its second season, the show prides itself on its accuracy and realism. I’ll share two things this oncologist thinks the show gets right related to communication. Hi, […]

Dr. Francisco Contreras is the President and Medical Director of the internationally renowned Oasis of Hope Hospital, founded by his father more than 60 years ago. Author of several books. He explains what cancer treatments are gaining results in Mexico but not available in the USA.

Dr. Francisco Contreras is the President and Medical Director of the internationally renowned Oasis of Hope Hospital, founded by his father more than 60 years ago. Author of several books. He explains what cancer treatments are gaining results in Mexico but not available in the USA.

Is it time to rewrite the playbook on oncology?In this episode of Medical Sales U, I sit down with Dr. David Waterhouse, a visionary leader in oncology and community research. From the emotional story that almost kept him out of medicine to the birth of Sarah Cannon (the world's largest community-based research network), this conversation is a masterclass in professional purpose, precision medicine, and the future of patient care.Whether you are a medical student, an aspiring pharma rep, or a healthcare professional, this episode reveals why the "community setting" is the true frontier of medical innovation and how the Hippocratic Oath must evolve in the age of AI.In this episode, we cover:The Personal Journey: Why Dr. Waterhouse tried to avoid oncology—and the mentor who changed his mind.Community Power: The evolution of Sarah Cannon and why 85% of cancer care happens in the community.Precision Medicine 101: How we moved from "untreatable" lung cancer to targeted therapies and biomarkers.The AI Trust Gap: A father and son's perspective on using AI as a partner without losing the human touch.The "Pro" Rep: What doctors actually value in a pharmaceutical partner (it's not a "sale"). CHAPTERS:00:00 - Introduction to Dr. David Waterhouse02:15 - Avoiding Oncology: A Personal Story of Loss05:30 - The Mentor Who Changed Everything09:45 - The Birth of the Sarah Cannon Network13:20 - Why Clinical Trials Belong in the Community18:10 - The Evolution of Lung Cancer Treatment23:50 - Precision Medicine & Biomarkers Explained28:15 - Closing the AI Trust Gap in Medicine34:00 - What Makes a Great Pharma Rep? (The Amgen Story)40:05 - The Hippocratic Oath vs. Fiduciary Duty44:20 - Personal Legacy: Family, Dogs, and SuccessConnect with Us:Follow Dr. David Waterhouse on Linked In: https://www.linkedin.com/in/david-waterhouse-md-mph-fasco-8a14b410/About Medical Sales U:We help high-performers—teachers, nurses, and professionals—break into the medical device and pharmaceutical sales industry through expert coaching and a proven community of winners. We help professionals transition into top-tier medical sales roles: medicalsalesu.com/Share this video with a colleague who needs to hear the truth about "patient-first" leadership.Subscribe for more deep dives into medical sales and healthcare innovation.#Oncology #MedicalSales #PrecisionMedicine #HealthcareInnovation #SarahCannon #ClinicalTrials #AIRules2026 #MedTech

This episode features Marwan G. Fakih, MD - Medical Oncologist, Professor, Department of Medical Oncology & Therapeutics Research, Deputy Director, City of Hope Comprehensive Cancer Center, Division Chief, GI Medical Oncology, Co-director, Gastrointestinal Cancer Program at City of Hope. Here he shares his thoughts around potentially screening younger patients, due higher rates of colon cancer. He also discusses the importance of educating patients to not overlook potential symptoms, clinical trials, and more.

In this episode of the Brown Surgery Podcast, PGY-4 general surgery resident Evan Mitchell sits down with a familiar face: Dr. Josh Cohen. Recently returning to the department as a surgical oncology attending, Dr. Cohen shares his journey from his residency training right here at Brown to his fellowship at Memorial Sloan Kettering, and what it's like starting his new practice.This conversation offers a grounded look into the realities of surgical oncology. Dr. Cohen discusses how to craft a career that balances broad operative skills with specialized cancer care, offering invaluable advice for medical students and residents trying to map out their futures.Key Topics Discussed:Choosing the Specialty: The unique appeal of head-to-toe operations, multidisciplinary care, and integrating complex cases with palliative care.Fellowship Nuances: The distinct differences in training and practice between Surgical Oncology and HPB fellowships.Advice for Trainees: Why you shouldn't stress about specializing too early, and the critical importance of finding a residency that builds a foundation as a strong general surgeon first.A Week in the Life: Managing a schedule dynamically split between the OR, clinic, and dedicated research time.Work-Life Balance & Dispelling Myths: Breaking down the misconception that surgical oncologists must have an intensely rigid personality, and how to maintain healthy boundaries while coordinating complex care across multiple specialties.Guest Bio:Dr. Josh Cohen completed his undergraduate studies at the University of Rochester and medical school at UMass. After completing his general surgery residency at Brown University, he pursued a fellowship at Sloan Kettering before returning to join the Brown surgical faculty.

What if the protein you're working so hard to eat is barely getting absorbed — and the answer has been growing in fresh water for four billion years?This week, I sat down with Catharine Arnston, CEO and Founder of EnergyBits and one of the world's leading experts on algae nutrition, who left a 25-year corporate career after her sister's breast cancer diagnosis sent her down a research rabbit hole she never climbed out of.Here's what blew my mind: when you eat 50 grams of chicken, your body can take two to three days to break it down — and you might only absorb 10% of it as usable amino acids. Five grams of spirulina delivers the equivalent amino acid payload. Instantly. Spirulina isn't even a plant — it's a bacteria with no cell wall, so it absorbs straight through your gums into your bloodstream in seconds.She dropped a bomb about GLP-1s: when you lose fat rapidly, you're not just losing fat — you're releasing the toxins stored inside it directly into your bloodstream. That's exactly when chlorella becomes non-negotiable.And the cancer conversation? Spirulina contains a blue pigment called phycocyanin found nowhere else on Earth. It can identify a cancer cell, strip out the very molecule that lets tumors grow, and trigger apoptosis — cancer cell death — while speeding up energy production in healthy cells. Oncologists are now measuring phycocyanin in blood plasma to track whether cancer is being killed.After hearing this, you'll never look at your protein sources — or your afternoon fatigue — the same way.Episode Links & Resources:Website: https://energybits.com/Use code HYDRATE for 20% offConnect with Tracy:Website: ⁠⁠⁠⁠⁠⁠https://tracyduhs.com/⁠⁠⁠⁠⁠⁠Hydration Shop: ⁠⁠⁠⁠⁠⁠https://sanctuarysd.com/⁠⁠⁠⁠⁠⁠Instagram: ⁠⁠⁠⁠⁠⁠@tracyduhs⁠⁠⁠⁠⁠⁠Flow FAM Community: ⁠⁠⁠⁠⁠⁠https://tracyduhs.com/join-flow-fam/

In this segment of Cancer Registry World, Laurie Kirstein, MD, FACS, a breast surgical oncologist in the Division of Surgical Oncology at Memorial Sloan Kettering Cancer Center and current Chair of the American College of Surgeons Commission on Cancer (CoC), discusses her vision and priorities for the CoC. Drawing on the power of cancer registry data, she highlights the essential role Oncology Data Specialists play in advancing cancer care, quality measurement, and program improvement. Tune in to hear how data-driven insights are shaping the future of oncology.

Welcome to the Oncology Brothers podcast! In this episode, we dived into the evolving treatment algorithms for bladder cancer following the latest data presented at GU ASCO 2026. Listen us on: Spotify: https://open.spotify.com/show/31BXhY9FM4gPWG10WgE11o Apple Podcast: https://podcasts.apple.com/us/podcast/oncology-brothers-practice-changing-cancer-discussions/id1653340966 Follow us on social media: X/Twitter: https://twitter.com/oncbrothers ⁠Instagram: https://www.instagram.com/oncbrothers Website: https://oncbrothers.com/ Join us as we explore: The role of immunotherapy in non-muscle invasive bladder cancer, highlighting the recent positive trials: CREST with Sasanlimab and POTOMAC with Durvalumab. Insights on the current standard of care and the implications of combining BCG with immunotherapy. The shift in treatment strategies for muscle-invasive bladder cancer, including the new standard of care with the EV-Pembro combination and its impact on pathologic complete response rates. The challenges and considerations in managing side effects associated with new therapies, as well as the importance of patient selection and coordination between urologists and medical oncologists. The emerging role of ctDNA in guiding treatment decisions and the ongoing discussions around the sequencing of therapies in refractory settings. Hope you enjoy this informative discussion that aims to keep you up to date in the world of cancer treatment, here focusing on bladder cancer. Subscribe to our channel for more episodes and discussions on the latest in oncology! #BladderCancer, #NMIBC, #MIBC, #Immunotherapy, #GU26, #OncologyBrothers